Tracking every rollback, reversal, and overreach — and the path back to the America we know.
Trump signed Executive Order 14298 modifying reciprocal tariff rates following discussions with China. The order adjusts tariff structures to reflect negotiations between the U.S. and People's Republic of China. This directly impacts American consumers through potential price changes on Chinese imports and affects U.S. businesses relying on Chinese goods.
This presidential determination invokes sections 1245(d)(4)(B) and (C) of the National Defense Authorization Act for Fiscal Year 2012. The determination addresses defense-related authorities and their application. The specific impacts on Americans depend on the determination's classified or restricted content details.
President Trump announced the removal of all tariffs and restrictions on whisky imports from Scotland, citing King Charles III's recent White House visit as the reason for the decision. The move was characterized by industry officials as a significant boost to trade relations and the whisky industry.
The Trump administration signed a notice continuing the national emergency declaration regarding securing the information and communications technology and services supply chain. This maintains restrictions and oversight on foreign ICT supply chains and related services. The action affects American technology companies, consumers reliant on ICT services, and federal procurement practices.
FCC Chair Brendan Carr issued an order requiring ABC to apply for early renewal of eight television station licenses originally not due until 2028–2031, citing alleged political bias in coverage. The action bypasses normal FCC renewal procedures and has drawn Democratic opposition as potential government retaliation against media outlets critical of Trump administration policies.
This notice extends the existing national emergency declaration regarding actions by the Syrian government. The continuation maintains ongoing sanctions and restrictions related to Syria. The action sustains current foreign policy measures targeting Syrian government activities.
Executive Order 14292 establishes new safety and security protocols for biological research activities. The order implements enhanced oversight and regulatory measures for laboratories and research institutions conducting biological work. This affects research institutions, universities, and private laboratories across the United States.
Executive Order 14293 signed on May 5, 2025, removes regulatory barriers to increase domestic production of critical medicines in the United States. The order streamlines FDA approval processes and reduces compliance requirements for pharmaceutical manufacturers. This aims to reduce American dependence on foreign drug sources and lower medication costs for consumers.
The Trump administration ousted FDA acting drug chief Dr. Tracy Beth Høeg, acting vaccines chief Katherine Szarama, and chief of staff Jim Traficant in a major leadership shake-up. The agency now lacks a permanent commissioner and stable leadership during critical drug approval and vaccine oversight functions. The departure of experienced regulators weakens FDA capacity to evaluate drug safety and vaccine efficacy during a period of potential regulatory rollback.
The Trump administration's budget law mandates work requirements for Medicaid beneficiaries, with Nebraska implementing the policy on May 1 and most states required to follow by January. The requirement forces many low-income Americans to prove employment to maintain health coverage, directly affecting millions of vulnerable populations who may struggle to meet work documentation standards.